The results of a clinical study, recently published in the journal Spinal Cord, indicate that the use of Cran-Max(R) Cranberry Concentrate for people with spinal cord injury resulted in a significant reduction in both the incidence of urinary tract infection (UTI) and the number of subjects with a UTI over a 12-month period. In the randomized, double-blind, cross-over trial, conducted at the Spinal Cord Injury Unit of the Veterans Administration Hospital in Boston, MA, 16 subjects had 21 UTIs while taking the placebo, compared to only six subjects who had seven UTIs while taking the Cran-Max cranberry concentrate.
In the article, published in the 2008 edition of the journal, researchers concluded, “Despite advances in the management of neurogenic bladder, urinary tract infection represents a leading cause of morbidity and hospitalization. Cranberry extract tablets should be considered for the prevention of UTI in spinal cord injury patients with neurogenic bladder.”
In the study, patients were randomly assigned to receive either Cran-Max tablets or placebo tablets for six months, followed by the alternative preparation for an additional six months. Of the 47 male subjects who completed the study, results showed that patients with a high glomerular filtration rate received the most benefit from the cranberry supplement.
According to Dean Mosca, President of Proprietary Nutritionals, Inc., marketer of Cran-Max, “Evidence has shown that antibiotics can be beneficial in preventing UTIs, but may cause negative side effects. In an earlier published study of older women with recurrent UTIs, Cran-Max was shown to be comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of UTIs, without the adverse side effects.”
“We’re confident that these latest study results showing the effectiveness of Cran-Max in supporting urinary tract health and improving quality of life for people with spinal cord injuries will serve as a strong foundation for people and their caregivers to consider Cran-Max as an effective tool to help support quality of life and wellbeing.”
Cran-Max is made from the whole cranberry, making it powerful enough to provide relief with just one capsule per day. It is the only cranberry supplement made using the patented Bio-Shield® technology that protects the cranberry from destruction by gastric acid, so that it can be delivered to the gastrointestinal tract for maximum effect.
Made through a proprietary process from 100 percent whole fresh cranberries, Cran-Max is a mixture of natural plant fibers that form a lignan-cellulose matrix and provides 25% more fiber and more antioxidant activity than cranberry juice.
Proprietary Nutritionals, Inc., a subsidiary of Pharmachem Laboratories, Inc., Kearny, NJ, markets Cran-Max and the Berry-Max™ line of berry concentrates, as well as other scientifically based, proprietary ingredients to the nutraceuticals marketplace including, Benexia Chia™, Celadrin® Joint Flexibility and Relief, Lactium® Stress management through nutrition, Perluxan® hops extract, Phase 2 Carb Controller™,and Sytrinol® Health Heart. For further information, visit, www.pnibrands.com, or email [email protected].